RE:RE:The “Right to Try” Drug BillIf this bill pass ,
the futur Phase 3 for ipf 4050 (wonder) must be seen different from that moment.
DIRECT COSTS can be recover
--So the cost of buying OFEV med.for phase3 by PLI can be charged to the patient.
--Direct costs as manufacturing the product can also be charged to the patient.
So the cost of the futur phase 3 trials for all the Bio pharma, those that have done well in phase 1 and 2 product ,can be reduce by a large amount!!!!!!!!!!!...In this way only, this bill can be seen as good.
What happened with Ryplazim is the best example of what this bill can correct!!!!!!!!!!!!